Synaptic dysfunction driven by toxic amyloid Aβ oligomers (Aβo) is one of the early events in Alzheimer’s disease (AD) leading to cognitive decline, disability, and death. We have shown that optoacoustic therapy/NPLT can be used for traumatic brain injury (TBI) treatment. We have also shown that mature neurons generated from the NPLT-treated rat hippocampal neural stem cells (NSCs) had significantly lower Aβo levels. Here we used a custom-made 808-nm optoacoustic system to study autophagy pathways changes induced by NPLT. Our results suggest that autophagy pathways are upregulated in NPLT-treated NSCs compared to sham which could lead to enhanced Aβo clearance.
Access to the requested content is limited to institutions that have purchased or subscribe to SPIE eBooks.
You are receiving this notice because your organization may not have SPIE eBooks access.*
*Shibboleth/Open Athens users─please
sign in
to access your institution's subscriptions.
To obtain this item, you may purchase the complete book in print or electronic format on
SPIE.org.
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.